Observational studyEuropean journal of clinical investigation2026
Prehospital Risk Stratification Using Unsupervised Machine Learning in STEMI.
Observational study in European journal of clinical investigation, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Artificial intelligence in prehospital assessment of acute coronary syndrome: a scoping review.BMC emergency medicine · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
backgroundST-elevation myocardial infarction (STEMI) exhibits substantial clinical heterogeneity complicating prehospital risk stratification. Traditional risk assessment tools often fail to capture the complexity of this condition. Machine learning offers opportunities to identify complex clinical patterns not readily apparent during prehospital care.
aimTo identify distinct phenotypes in STEMI patients using unsupervised machine learning algorithms based on prehospital parameters, and to determine their association with short-term mortality and cardiovascular outcomes.
methodsProspective multicenter observational cohort study including adult patients with prehospital STEMI code activation transported by emergency medical services from January 2022 to August 2025. Only EMS-transported patients were included; those who self-presented to the emergency department were excluded. Prehospital variables, including demographic, clinical, and procedural data, were used for clustering. Factor Analysis of Mixed Data and a two-step clustering: hierarchical clustering (exploring structure and number of clusters) and k-means (clustering assigning patients to phenotypes). A Random Forest classifier with SHapley Additive exPlanations values was used to identify variables contributing to cluster assignment. The primary outcome was 30-day all-cause mortality, assessed through follow-up records.
resultsAmong 744 patients (median age, 65 years; 76.3% male) unsupervised clustering identified three distinct phenotypes: Phenotype-1 (70.3%) characterized by hemodynamic stability, vessel locations, Killip class I presentation (70.6%), and favourable laboratory parameters; Phenotype-2 (24.3%) presented higher comorbidity burden and metabolic derangements; and Phenotype-3 (5.4%) exhibiting profound hemodynamic instability, severe respiratory failure, out-of-hospital cardiac arrest with return of spontaneous circulation (87.5%), Killip class IV presentation (67.5%), and marked metabolic derangements. The 30-day mortality rates were: 3.4% in Phenotype-1, 22.1% in Phenotype-2, and 75.0% in Phenotype-3.
conclusionsThree clinically distinct STEMI phenotypes were identified with markedly different mortality risks and treatment requirements during prehospital care. Phenotypes derived from readily available prehospital parameters may facilitate early risk stratification, optimize triage decisions, and guide individualized therapeutic strategies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.